WhatsApp Image 2023-11-17 at 16.35.07
logo-uco

Welcome to Bionatura journal, published by its partners

Centro Ecuatoriano de Biotecnología y Ambiente (CEBA) and Universidad Católica de Oriente (UCO)

Journal Scope

Bionatura is dedicated to publishing manuscripts on topics concerning all aspects of biotechnology and life sciences.

The topics include: Agriculture, Bioinformatics, Biomedicine, Bioscience, Biotechnology, Epidemiology, Immunology, insects, Medical case report, Microbiology, Mycology, Nanomedicine, Nanoparticles, Parasitology, Pharmacological Research, Plants (Botany), Pollution, Polymers, Veterinary, Histology,Virology are also considered.
Review articles about the ethical aspects of biomedical research and clinical practice (Bioethics) are welcomed.

Costs of publication and download of articles

The publication, editing and downloading of any material from Bionatura journal articles are free of charge.
if you receive an email that is not from editor@revistabionatura.org ; cebaecuador@gmail.com it is fake do not respond to it.

Open access

All articles published by Bionatura journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Bionatura is a platinum open access journal

Periodical publication

Bionatura publishes four annual numbers (Quarterly). This journal uses the peer review system for the evaluation of submitted manuscripts.

Peer review system

Bionatura uses the peer review system and all publications received are evaluated in anti-plagiarism programs

Bionatura Template and ICMJE form

  • Each author or group of authors must fill out the attached document from the International Committee of Medical Journal Editors stating the ethical aspects of their research and that they did not have to pay any fee for the editing and publication of their article in Bionatura. To download the ICMJE form, please click here.
  • Word doc Bionatura Template

 

Online ISSN 1390-9355
Impreso ISSN 1390-9347

Vol 9 No 2 2024

INDEXADA EN

INDEXADA EN